CCM Pharmaceuticals ("CCMP") is a division under Chemical Company of Malaysia Berhad, a company listed on Bursa Malaysia's Main Board. CCMP is principally engaged in the manufacturing, distributing, importing and exporting of pharmaceutical products and medicines.

The division consists of the following:-

  1. Manufacturing Units
    1. Upha Pharmaceutical Manufacturing (M) Sdn Bhd
    2. CCM Pharma Sdn Bhd
  2. Marketing Unit
    CCM Pharmaceuticals Sdn Bhd (Formerly known as Upha Corporation (M) Sdn Bhd)
  3. Retail Outlet
    Prima-health Pharmacy (Retail) Sdn Bhd

CCMP is one of the leading local manufacturers of quality pharmaceutical products, producing over hundreds of pharmaceuticals products across a wide therapeutic group which includes analgesics, antibacterial, antihistamines and many others. It also manufactures over a hundred health and food supplements such as vitamins and herbal preparations. Apart from being a contract manufacturer for multinational pharmaceutical companies, CCMP also exports its own products throughout ASEAN, Asia Pacific and other parts of the world.


CCMP's manufacturing units have been certified as a manufacturer meeting the Good Manufacturing Practice ("GMP") standards of the Ministry of Health, Malaysia and the Pharmaceutical Inspection Convention and Cooperation Scheme ("PIC/S"). Its softgel plant has also been certified by the Australian Therapeutic Goods Administration ("TGA"). Its products under the brands Champs, Flavettes, Naturalle and Proviton are certified "HALAL" by JAKIM. CCMP also adheres to Good Laboratory Practice ("GLP") and Good Storage Practice ("GSP"). All these certifications ensure that the quality and hygiene aspects of CCMP's products are consistently of high standard.

CCMP's facilities cater to high speed and large-scale manufacturing of a wide variety of pharmaceutical products. These include sophisticated encapsulating and tabletting machines, blister pack machines, sachet packing machine, high-speed liquid fillers, blender and fluidised bed mixer/ granulator/driers.

The dosage forms of its manufactured products are as follows:

  1. Tablet
  2. Softgel
  3. Cephalosporin
  4. Sterile eye/ear drop
  5. Controlled Release / Sustained Release Tablet
  6. Capsules
  7. Liquid
  8. Penicillin
  9. Syrup
  10. Granules

The main therapeutic areas of CCMP's ethical products are as follows:

  • Cardiovascular - e.g. Perinace, Vascor
  • Gastrointestinals - e.g. Omesec, X'tac
  • Antibacterials - e.g. Efurox, Enoxin
  • Ophthalmology - e.g. Nicol, Neo Deca
  • Cough & Cold - e.g. Promedyl, Allavin
  • Antihistamines - e.g. Carin, Simtec

The following products have undergone Bioequivalent (BE) studies successfully:

  • Omesec (Omeprazole)
  • Imdex CR (Isosorbide-5-Mononitrate Controlled-Release)
  • Salmax CR (Salbutamol Controlled-Release)
  • Hepirax D (Acyclovir Dispersible)
  • Zolterol SR (Diclofenac Sodium Sustained-Release)
  • Trenlin SR (Pentoxyfyllin Sustained-Release)
  • Vascor (Simvastatin)
  • Uphaxicam (Piroxicam)
  • Uphalexin (Cephalexin)
  • Kezoral (Ketoconazole)
  • X'Tac (Ranitidine)
  • Cimetidine (Cimetidine)
  • Metformin (Metformin)

Omesec and Vascor are well accepted by both locals and overseas professionals. They have been enlisted in both local and overseas government tender products.

Omesec - A product that past both local and oversea stringent BE Test in 1999 and 2002. It also received Industry Excellence Award 2004 (Innovative Product) from MITI. Proving beyond all doubts that these products can definitely withstand the test of time.

CCMP's products have also been honoured with numerous awards locally as well as in the region as follows:-

Year Award Brand
2005 Super Branding
(PARENTS Magazine - Hong Kong)

2005 Guardian Customers' Choice Champs
2005 Watsons Best Sugar Free Vitamin C Flavettes
2004 Watsons Best Children Vitamin Range Champs
2004 MITI Industry Excellence - Innovative Product Omesec
2004 Superbrands Malaysia Champs
Year Award Brand
2004 Watsons Best Children Vitamin Range Champs
2003 Guardian Health & Beauty
Consumer Choice
2003 Guardian Health & Beauty
Consumer Choice
1999 MITI Industry Excellence - Pioneer in Research of Excellent Product Quality Proviton


  1. Capital Expenditure
    A new state-of-the-art manufacturing facility is being built on a 90,000 sq ft area adjacent to the current manufacturing facilities in Bangi. The new plant, costing RM50m, is scheduled to be commissioned in 2007 and would be equipped with high speed machines employing the latest technology to cater to the demands from the region.

  2. Regional
    New offices and workforce are being set up at key countries in the region: Singapore, Hong Kong, Indonesia and Vietnam.

Lot 2 & 4 Jalan P/7 Bangi Industrial Estate
Section 13 Bandar Baru Bangi
43650 Kajang, Selangor Darul Ehsan
Tel : 603-8924 2188 / Fax : 603-8926 4469

Copyright © 2019 The Malaysian Organisation of Pharmaceutical Industries. All Rights Reserved.
Powered by Netxtreme Onesolution Sdn Bhd